Dr Arner on the Role of SETD2 Loss in Tumor Growth and Metastasis in ccRCC
Emily Arner, PhD, discusses research on the role of SETD2 loss in metastatic clear cell renal cell carcinoma ccRCC.
Source: onclive.com
Stay updated with breaking news from Emily Arner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emily Arner, PhD, discusses research on the role of SETD2 loss in metastatic clear cell renal cell carcinoma ccRCC.
Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) -; the most common form of the chronic autoimmune disease lupus.